Bjorg Thorsteinsdottir, MD, Annika Beck, and Jon C. Tilburt, MD, MPH
Good clinicians understand why a patient is asking for a test or treatment, and their skillful counseling can often stem the tide of requests for marginally beneficial tests and procedures.
AMA J Ethics. 2015; 17(11):1028-1034. doi:
10.1001/journalofethics.2015.17.11.ecas2-1511.
Dr Nat Mulkey and Dr Carl G. Streed Jr join Ethics Talk to discuss their article coauthored with Dr Barbara M. Chubak, "A Call to Update Standard of Care for Children With Differences in Sex Development."
Charles E. Binkley, MD, Michael S. Politz, MA, and Brian P. Green, PhD
If the safe-and-effective standard for judging devices’ potential as therapy or enhancement is inadequate, one might wonder whether BCI regulation should be overseen by the FDA.
AMA J Ethics. 2021; 23(9):E745-749. doi:
10.1001/amajethics.2021.745.
Dr Charles Binkley joins Ethics Talk to discuss his article, coauthored with Michael Politz and Dr Brian Green: "Who, If Not the FDA, Should Regulate Implantable Brain-Computer Interface Devices?"
Expedited partner therapy is an ethical and effective treatment for sexually transmitted infection, provided patients are reliable messengers to partners.
AMA J Ethics. 2016; 18(3):215-228. doi:
10.1001/journalofethics.2016.18.3.ecas3-1603.
Barry DeCoster, PhD and Lisa Campo-Engelstein, PhD
Expedited partner therapy is an ethical and effective treatment for sexually transmitted infection, provided patients are reliable messengers to partners.
AMA J Ethics. 2016; 18(3):215-228. doi:
10.1001/journalofethics.2016.18.3.ecas3-1603.